TITLE 856 INDIANA BOARD OF PHARMACY

Temporarily amends 856 IAC 2-2-2 to add drug compounds to Schedule I. Repeals LSA Document #20-516(E), posted at 20201014-IR-856200516ERA. Statutory authority: IC 25-26-13-4.1. Effective 30 days after filing with the Publisher.

SECTION 1. (a) This SECTION is supplemental to 856 IAC 2-2-2.

(b) Unless specifically excepted or unless listed in another schedule, any of the following substances, including its analogs, isomers, esters, ethers, salts and salts of isomers, esters, and ethers whenever the existence of such analogs, isomers, esters, ethers, and salts is possible within the specific chemical designation:

(1) MDMB-4en-PINACA; Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H[1]indazole-3-carboxamido)butanoate.

(2) 4F-MDMB-BICA; 4-fluoro MDMB-BICA, 4F-MDMB-BUTICA; Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3- dimethyl-butanoate.

(3) Isotonitazene. Synonyms: N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1 H- benzimidazol-1-yl)ethan-1-amine.

DIN: 20221214-IR-856220360ERA

Composed: May 03,2024 7:09:43AM EDT

A PDF version of this document.